CHESS ROBERT bought NKTR

September 30, 2025 · Form 4 insider transaction

CHESS ROBERT bought 8,000 shares of Nektar Therapeutics at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction

Acquired (buy-side)

8,000

Price

$0.00

Total value

N/A

InsiderCHESS ROBERT

RoleDirector

CompanyNektar Therapeutics (NKTR)

SecurityStock Option

Transaction codeA — Grant or award

Transaction dateSeptember 30, 2025

Filing dateOctober 1, 2025

Shares owned after8,000

OwnershipDirect

10b5-1 planNo

AmendedNo

Footnotes

This stock option vests in substantially equal monthly installments over the one-year period beginning on September 30, 2025.

View the original Form 4 on SEC EDGAR